- Title: Subtitle
- QOL Improvements in NETTER-1 Phase III Trial in Patients With Progressive Midgut Neuroendocrine Tumors
- Creators
- Jonathan Strosberg - H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USAEdward Wolin - College Station Medical CenterBeth Chasen - Univ Texas MD Anderson Canc Ctr, Houston, TX, USAMatthew Kulke - DanaDavid Bushnell - University of IowaMartyn Caplin - The Royal Free HospitalRichard P. Baum - Zent Klin Bad Berka, Bad Berka, GermanyPamela Kunz - Stanford UniversityTimothy Hobday - College Station Medical CenterAndrew Hendifar - College Station Medical CenterKjell Öberg - Endokrin tumörbiologiMaribel Lopera Sierra - Adv Accelerator Applicat, St Genis Pouilly, FrancePhilippe Ruszniewski - Hop Beaujon, Clichy, FranceEric Krenning - Erasmus MC
- Resource Type
- Abstract
- Publication Details
- Pancreas, Vol.47(3), p.355
- ISSN
- 0885-3177
- eISSN
- 1536-4828
- Comment
- DOI: 10.1097/MPA.0000000000000997
- Language
- English
- Date published
- 2018
- Academic Unit
- Radiology
- Record Identifier
- 9984320099302771
Abstract
QOL Improvements in NETTER-1 Phase III Trial in Patients With Progressive Midgut Neuroendocrine Tumors
Pancreas, Vol.47(3), p.355
2018
Abstract
Details
Metrics
11 Record Views